Recent comparative gene expression profiling of primary and metastatic RCC shows great differences in the TGF-β, Wnt/β-catenin and EMT signalling pathways [10] through data analysis in drug-resistant RCC. The gene discussed is TGFB1; the disease is renal cell carcinoma.